Literature DB >> 22868902

Not simply a matter of psoriatic arthritis: epidemiology of rheumatic diseases in psoriatic patients.

Gabriele De Marco1, Angelo Cattaneo, Norma Battafarano, Ennio Lubrano, Carlo G Carrera, Antonio Marchesoni.   

Abstract

This study investigated the occurrence of rheumatic conditions (RCs) in a psoriasis (PSO)-dedicated dermatological clinic. PSO subjects with musculo-skeletal discomfort, and/or carrying signs (articular/systemic, even asymptomatic) of RCs; and/or suffering flares of previously established psoriatic arthritis (PsA) were referred to rheumatologist for evaluation. Laboratory tests/imaging were performed as needed. Categorization adhered to RCs classification endorsed by the Italian Society of Rheumatology. Of the 1,200 psoriatic subjects, 277 (23.1 %) were enrolled (146 females). The mean age was 55.7 years (range 21-81), PSO duration was 13.5 years (range 0-62). Thirty-seven patients (13.4 %) were asymptomatic. On an average, 92 (7.6 %) patients/year were evaluated, of whom 79.4 % näive to rheumatological consultations (NRC). Osteoarthritis (OA) and PsA (isolated or combined) showed the highest prevalence, with 156 (56.3 %) and 110 cases (39.7 %), respectively. Among NRC subjects, the mean PsA annual incidence was 29.5 % (standard error of the mean ±5.4 %). Other RCs, isolated or associated with PsA/OA, were diagnosed in 31 cases (11.2 %). Thirty-two subjects (11.5 %) had arthralgias, 20 of whom due to congenital/mechanical disorders, the remaining were unclassifiable. In conclusion, the largest part (88.5 %) of PSO subjects referred to rheumatologist showed some RCs. On annual basis, 29.5 % of näive enrolled patients were diagnosed as PsA.

Entities:  

Mesh:

Year:  2012        PMID: 22868902     DOI: 10.1007/s00403-012-1281-x

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  9 in total

Review 1.  The Epidemiology of Psoriatic Arthritis.

Authors:  Alexis Ogdie; Pamela Weiss
Journal:  Rheum Dis Clin North Am       Date:  2015-09-11       Impact factor: 2.670

Review 2.  Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.

Authors:  Teo Soleymani; Soumya M Reddy; Jeffrey M Cohen; Andrea L Neimann
Journal:  Curr Rheumatol Rep       Date:  2017-11-20       Impact factor: 4.592

Review 3.  Epidemiology of Psoriasis and Psoriatic Arthritis in Italy-a Systematic Review.

Authors:  Francesca Prignano; Veronica Rogai; Elisabetta Cavallucci; Alessandro Bitossi; Volker Hammen; Fabrizio Cantini
Journal:  Curr Rheumatol Rep       Date:  2018-05-30       Impact factor: 4.592

Review 4.  Multidisciplinary dermatology-rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review.

Authors:  Tatiana Cobo-Ibáñez; Virginia Villaverde; Daniel Seoane-Mato; Santiago Muñoz-Fernández; Mercedes Guerra; Petra Díaz Del Campo; Juan D Cañete
Journal:  Rheumatol Int       Date:  2015-10-05       Impact factor: 2.631

5.  Evaluation of the prevalence of musculoskeletal conditions in consecutive patients with skin psoriasis: a descriptive cross-sectional study.

Authors:  Astrid Dauchez; Maxime Dougados; Mathilde Kemula; Elodie Regnier; Selim Aractingi; Anna Moltó
Journal:  Rheumatol Int       Date:  2022-02-13       Impact factor: 2.631

6.  Psoriatic arthritis epidemiology, comorbid disease profiles and risk factors: results from a claims database analysis.

Authors:  Jürgen Rech; Michael Sticherling; Daniel Stoessel; Mona H C Biermann; Benjamin M Häberle; Maximilian Reinhardt
Journal:  Rheumatol Adv Pract       Date:  2020-07-10

Review 7.  Psoriasis and comorbid diseases: Epidemiology.

Authors:  Junko Takeshita; Sungat Grewal; Sinéad M Langan; Nehal N Mehta; Alexis Ogdie; Abby S Van Voorhees; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2017-03       Impact factor: 11.527

Review 8.  Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era.

Authors:  Dennis McGonagle; Kay-Geert A Hermann; Ai Lyn Tan
Journal:  Rheumatology (Oxford)       Date:  2014-09-16       Impact factor: 7.580

9.  Hidradenitis Suppurativa and Concurrent Psoriasis: Comparison of Epidemiology, Comorbidity Profiles, and Risk Factors.

Authors:  Andreas Pinter; Georgios Kokolakis; Juergen Rech; Mona H C Biermann; Benjamin M Häberle; Jan Multmeier; Maximilian Reinhardt
Journal:  Dermatol Ther (Heidelb)       Date:  2020-06-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.